Sermion, 5 mg 30 pcs.

Pharmacodynamics

A drug that improves cerebral and peripheral blood flow, with alpha-adrenoblocking as well as metabolism-activating effects.

Limits vascular resistance, increases arterial blood flow and oxygen and glucose consumption by brain tissue. Lowers pulmonary vascular resistance. Reduces platelet aggregation and improves hemorheological indicators.

Enhances blood flow velocity in the blood vessels of the upper and lower extremities, especially in blood flow disorders caused by functional arteriopathy. Clinical trials have shown high effectiveness of Sermion in disorders of cerebral circulation and insufficiency of arterial blood flow in the vessels of the upper and lower extremities.

The administration of Sermion in therapeutic doses generally has no effect on BP. In patients with arterial hypertension, the drug may cause a gradual decrease in BP.

Pharmacokinetics

There have been no studies of the pharmacokinetics of Sermion.

Indications

Active ingredient

Composition

Active substances:

Nicerholin – 5 mg.

How to take, the dosage

In the oral route, the drug is prescribed 5-10 mg 3 times a day at equal intervals between doses for a long period of time.

The drug should be taken between meals to improve absorption.

In some cases it is suitable to start the therapy with parenteral administration (Sermion por.lyoph.d/in. 4 mg fl. 4 ml [with solution] unit 4 Pfizer) and then switch to oral administration during maintenance therapy.

Interaction

In concomitant use of Sermion may potentiate the effect of hypotensive drugs.

Special Instructions

Impact on the ability to drive vehicles and other mechanisms requiring high concentration

Cermion improves concentration.

The effect of the drug on the ability to drive vehicles and operate mechanisms has never been studied.

Perhaps due to the disease for which the drug is prescribed, caution is recommended when driving or operating machinery.

Contraindications

Side effects

Cardiovascular system disorders: rare – sensation of fever and flushes to the face.

CNS disorders: rarely – somnolence, insomnia.

Digestive system disorders: rare – mild gastric disorders.

Overdose

No cases of overdose have been described at this time.

Similarities